Opioid analgesia: Perspective on right use and utility

Pain Physician

Volumn 10, Issue 3, 2007, Pages 479-491

  Ballantyne, Jane C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Addiction; Chronic pain; Ethics; Opioids; Side effects; Utility

Indexed keywords

CODEINE; IBUPROFEN; LEVORPHANOL; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PARACETAMOL; PLACEBO;

AGGRESSION; ARTHRITIS; CANCER PAIN; CHRONIC PAIN; CLINICAL DECISION MAKING; CLINICAL TRIAL; COMMUNITY CARE; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CRIMINAL LAW; CULTURAL FACTOR; DRIVE; DRUG DEPENDENCE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG LEGISLATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; DRUG WITHDRAWAL; EMPLOYMENT STATUS; ESTROGEN BLOOD LEVEL; EUPHORIA; EVIDENCE BASED MEDICINE; FEMALE INFERTILITY; GENETIC PREDISPOSITION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERALGESIA; HYPOGONADISM; IMMUNE DEFICIENCY; LIBIDO DISORDER; LONG TERM EXPOSURE; LOW DRUG DOSE; MALE INFERTILITY; MEDICAL ETHICS; NAUSEA; NEUROPATHIC PAIN; PATIENT CARE; PATIENT RIGHT; PATIENT SELECTION; PRURITUS; QUALITY OF LIFE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SHORT COURSE THERAPY; SIDE EFFECT; SOCIAL PSYCHOLOGY; SOCIAL STATUS; TESTOSTERONE BLOOD LEVEL; ANALGESIA; DRUG ADMINISTRATION; DRUG TOLERANCE; ETHICS; INTRACTABLE PAIN; OPIATE ADDICTION; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; STANDARD; TREATMENT FAILURE;

ANALGESIA; ANALGESICS, OPIOID; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; HUMANS; OPIOID-RELATED DISORDERS; PAIN, INTRACTABLE; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT FAILURE;

EID: 34250888139     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Porter J, Jick H. Addiction rare in patients treated with narcotics (letter). N Engl J Med 1980; 302:123
2. AAPM Council on Ethics. American Academy of Pain Medicine. Ethics Charter Available at: www.painmed.org/productpub/pdfs/EthicsCharter.pdf. 2005;
3. Carr DB, Goudas LC. Acute pain. Lancet 1999; 353:2051-8.
4. Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet 2003; 362:1921-8.
5. Brennan TJ, Kehlet H. Preventive analgesia to reduce wound hyperalgesia and persistent postsurgical pain. Not an easy path. Anesthesiol 2005; 103:681-683.
6. Dubois MY. The birth of an ethics charter for pain medicine. Pain Med 2005; 6:201-2.
7. Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain medicine, controlled substances, and state medical board policy: a decade of change. J Pain Symptom Manage 2002; 23:138-47.
8. Dole V. What we have learned from three decades of methadone maintenance treatment. Drug & Alcohol Review 1994; 13:3-4.
9. Brecher E, Editors of Consumer Reports Magazine. How well does methadone mainenance work? In: The Consumers Union Report on Licit and Illicit Drugs. Schaffer Library of Drug Policy. Available at: http://www.druglibrary.org/schaffer/Library/studies/cu/cument/htm Accessed 10/12/2006.2006;
10. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986; 25:171-186.
11. Tennant FS, Uelman GF. Narcotic maintenance for chronic pain: medical and legal guidelines. Postgrad Med 1983; 73:81-94.
12. Bouckoms A, Masand P, Murray G, Cassem E, Stern T, Tesar G. Chronic nonmalignant pain treatment with long term analgesics. Ann Clin Psychiatry 1992; 4:185-192.
13. Kalso E, Edwards J, Moore R, McQuay H. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112:372-380.
14. Kjaersgaard-Andersen P, Nafei A, Skov O, Madsen F, Andersen HM, Kroner K, Hvass I, Gjoderum O, Pedersen L, Branebjerg PE. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip: a randomised, double-blind, multicentre study. Pain 1990; 43:309-318.
15. Moran C. MST continus tablets and pain control in severe rheumatoid arthritis. Br J Clin Res 1991; 2:1-12.
16. Arkinstall W, Sandler A, Groghnour B, Babul N, Harsanyi Z, Darke AC. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized placebo-controlled clinical trial. Pain 1995: 62:168-178.
17. Moulin DE, Iezzi A, Amireh R, Sharpe WKJ, Boyd D, Merskey H. Randomized trial of oral morphine for chronic noncancer pain. Lancet 1996; 347:143-147.
18. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain: a randomized prospective study. Spine 1998; 23:2591-2600.
19. Sheather-Reid RB, Cohen ML. Efficacy of analgesics in chronic pain: a series of n-of-1 studies. J Pain Symptom Manage 1998; 15:244-252.
20. Watson CPN, Babul N . Efficacy of oxycodone in neuropathic pain. A randomized trial in postherpetic neuralgia. Neurology 1998; 50:1837-1841.
21. Caldwell JR, Hale ME, Boyd RE, Hague JM, Iwan T, Shi M, Lacouture PG. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatology 1999; 26:862-869.
22. Peloso PM, Bellamy N, Bensen W, Thomson GTD, Harsanyi Z, Bubul N, Darke AC. Double blind randomized placebo-control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000; 27:764-771.
23. Roth SH, Fleischmann RM, Burch RX, Dietz F, Bochow B, Rapaport RJ, Rutstein J, Lacouture PG. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain. Arch Intern Med 2000; 160:853-860.
24. Huse E, Larbig W, Flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain 2001; 90:47-55.
25. Caldwell JR, Rapoport RJ, Davis JC, Offenberg HL, Marker HW, Roth SH, Yuan W, Eliot L, Babul N, Lynch PM.Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002; 23:278-291.
26. Maier C, Hildebrandt J, Klinger R, Henrich-Eberl C, Lindena G. Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS). Pain 2002 ; 97:223-233.
27. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, Royall RM, Max MB. A placebo-controlled trial comparing the analgesic and cognitive effects of opioids and tricyclic antidepressants in postherpetic neuralgia. Neurology 2002; 59:1015-1021.
28. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.[see comment]. Neurology 2003; 60:927-934.
29. Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliative Medicine 2003; 17:576-587.
30. Rowbotham MD, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003; 348:1223-32.
31. Watson CPN, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105:71-78.
32. Harke H, Gretenkort P, Ladleif HU, Rahman S, Harke O. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. Anesth Analg 2001; 92:488-495.
33. Ballantyne J, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349:1943-1953.
34. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic nonmalignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005; 7:R1046-1051.
35. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain. An epidemiological study. Pain 2006; 125:172-179.
36. Ballantyne JC. Opioids for chronic pain: taking stock. Pain 2006; 125:3-4.
37. Katz N. Methodological issues in clinical trials of opioids for chronic pain. Neurology 2005; 65:S32-49.
38. Mao J. Opioid induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 2002; 100:213-217.
39. Mercadante S. Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 1999; 86: 1856-1866.
40. Schofferman J. Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage 1993; 8:279-288.
41. Harden RN. Chronic opioid therapy: another reappraisal. APS Bulletin 2002; 12:
42. Devulder J, Richarz U, Nataraja SH. Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain. Curr Med Res Opin 2005; 21:1555-1568.
43. Becker N, Sjogren P, Bech P, Olsen AK, Eriksen J. Treatment outcome of chronic non-malignant pain patients managed in a danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain 2000; 84:203-211.
44. Bruera E, Macmillan K, Hanson J, MacDonald N. The cognitive effects of the administration of narcotic analgesic in patients with cancer pain. Pain 1989; 339:13-16.
45. Vainio A, Ollila J. Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995; 346:667-70.
46. Galski T, Willimas B, Ehle HT. Effects of opioids on driving ability. J Pain Symptom Manage 2000; 19:200-8.
47. Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage 1998; 15:185-194.
48. Tassain V, Attal N, Fletcher D, Brasseur L, Degieux P, Chauvin M, Bouhassira D. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain 2003; 104:389-400.
49. Kamboj SK, Tookman A, Jones L, Curran HV. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 2005; 117:388-395.
50. Sjogren P, Christrup LL, Petersen MA, Hojsted J. Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre. Eur J Pain 2005; 9:453-462.
51. Fishman SM, Wilsey B, Mahajan G, Molina P. Methadone reincarnated: novel clinical applications with related concerns. Pain Med 2002; 3:339-348.
52. Mendelson JH, Meyer RE, Ellingboe J, Mirin SM, McDougle M. Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther 1975; 195:296-302.
53. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002; 3:377-384.
54. Daniell HW. Narcotic-induced hypogonadism during therapy for heroin addiction. Journal of Addictive Diseases 2002; 21:47-53.
55. Finch PM, Roberts LJ, Price L, Hadlow NC, Pullan PT. Hypogonadism in patients treated with intrathecal morphine. Clinical Journal of Pain 2000; 3:251-254.
56. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996; 11: 71-80.
57. Abs R, Verhelst J, Maeyaert J, Van Buyten J P, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J Clinic Endocrinology & Metabolism 2000; 85:2215-2222.
58. Roy S, Loh H H. Effects of opioids on the immune system. Neurochem Res 1996; 21:1375-1386.
59. Risdahl J M, Khanno K V, Peterson P K, Molitor T W. Opiates and infection. J Neuroimmunol 1998; 83:4-18.
60. Page GG. Immunologic effects of opioids in the presence or absence of pain. J Pain Symptom Manage 2005; 29:S25-31.
61. Rahim RT, Adler MW, Meissler JJ Jr, Cowan A, Rogers TJ, Geller EB, Eisenstein TK. Abrupt or precipitated withdrawal from morphine induces immunosuppression. J Neuroimmunol 2002; 127: 88-95.
62. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC 1994;
63. Savage S, Covington E, Ehit H, Hunt J, Joranson D, Schnoll S. Definitions related to the use of opioids for the treatment of pain. A consensus document from the American Academy of Pain Medicine, the American Pain Society and the American Society of Addiction Medicine 2001;
64. Office of Applied Studies. National Survey on Drug Use and Health. Substance Abuse and Mental Services Administration (SAMHSA) 2004. http://oas.samhsa.gov/NHSDA/2k3NSDUH/2keresults.htm:
65. Fishbain D, Rosomoff H, Rosomoff R. Drug abuse, dependence and addiction in chronic pain patients. Clin J Pain 1992; 8:77-85.
66. Hyman S. Dispelling the myths about addiction. Institute of Medicine. National Academy of Sciences Press, Washington 1997; 444-46.
67. Kreek MJ. Drug addictions: molecular and cellular endpoints. Ann N Y Acad Sci 2001; 937:27-49.
68. Cami J, Farre M. Drug addiction. N Engl J Med 2003; 349:975-986.
69. Hyman S, Malenka R. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001; 2:695-703.
70. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006; 29:565-598.
71. Koob G, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropharm 2001; 24: 97-129.
72. Koob G, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278:52-58.
73. Koob G, Maldonado R, Stinus L. Neural substrates of opiate withdrawal. Trends Neurosci 1992; 15:186-191.
74. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 1997; 278:58-63.
75. Nestler EJ. Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 2004; 25: 210-218.
76. Kreek MJ, Nielsen DA, LaForge KS. Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med 2004; 5:85-108.
77. Fishbain D, Goldberg M, Meagher B, Steele R, Rosomoff H. Male and Female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain 1986; 26:181-197.
78. Gatchel RJ. Comorbidity of chronic pain and mental health disorders: the biopsychosocial perspective. American Psychologist 2004; 59: 795-805.
79. Polatin P, Kinney R, Gatchel R, Lillo E, Mayer T. Psychiatric illness and chronic low-back pain. The mind and the spine--which goes first? Spine 1993; 18:66-71.
80. Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146:116-1127.
81. Chabal C, Erjavec M, Jacobson L, Mariano A, Chanev E. Prescription opiate abuse in chronic pain patinets: clinical criteria, incidence and predictors. Clin J Pain 1997: 13:150-155.
82. Saper J, Lake A, Hamel R, Lutz T, Branca B, Sims D, Kroll MM. Daily scheduled opioids for intractable head pain: long-term observations of a treatment program. Neurology 2004; 62:1687-1694.
83. Hojsted J, Sjogren P. Addiction to opioids in chronic pain patients: A literature review. Eur J Pain 2006;
84. Brennan TA. Just Doctoring. Medical Ethics in the Liberal State. University of California Press, Berkeley and Los Angeles, CA. 1991a; p 3 (Brennan quotes the Webster Dictionary definition of liberalism)
85. Szasz T, Hollender J. The Basic Model of the Doctor-Patients Relationship. Arch Int Med 1956: 97: 85-90.
86. Advisory Commission on Consumer Protection and Quality in the Health Care Industry. Patients' Rights and Responsibilities http://www.consumer.gov/qualityhealth/rights/htm 1998;
87. Joranson D, Gilson A. State intractable pain policy: Current status. APS Bulletin 1997; 7:7-9.
88. Drug Enforcement Administration. Physician's Manual. Alexandria, VA. 1990;
89. Weaver M, Schnoll S. Opioid treatment of chronic pain in patients with addiction. J Pain & Palliat Care Pharmacotherapy 2002; 16:5-26.
90. Collins E, Streltzer J. Should opioid analgesics be used in the management of chronic pain in opiate addicts? Am J on Addictions 2003; 12:93-100.
91. Newman R. Analgesia and opiate addicts. Am J on Addictions 2004; 13:494.
92. Dunbar S, Katz N. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: Report of 20 cases. J Pain Symptom Manage 1996; 11:163-167.
93. Kennedy J, Crowley T. Chronic pain and substance abuse: a pilot study of opioid maintenance. J Subst Abuse Treat 1990; 7:233-238.
94. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain with "problematic" substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage 1998;16:355-363.
95. Friedman R, Li V, Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Medicine 2003; 4:182-185.
96. Passik SD, Kirsh KL, Whitcomb L, Portenoy RK, Katz NP, Kleinman L, Dodd SL, Schein JR. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clinical Therapeutics 2004; 26:552-561.
97. Adams L, Gatchel R, Robinson RC, Polatin P, Gajraj N, Deschner M, Noe, C. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Sympt Manage 2004; 27:440-459.
98. Butler S, Budman S, Fernandez K, Jamison R. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004; 112:65-75.
99. Webster L, Webster R. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005; 6:432-442.
100. Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: Predicting outcomes of opioid prescribing for chronic pain. J Pain 2006; 7:671-681.
101. Passik SD, Kirsh KL. Opioid therapy in patients with a history of substance abuse. CNS Drugs 2004; 18:13-25.
102. Sullivan M. Ethical principles in pain management. Pain Med 2001; 2:106-111.
103. Veach RM. The Theory of Medical Ethics. New York: Basic Books pp23. 1981.